Literature DB >> 3082008

Role of platelet-activating factor-acether in mediating guinea pig anaphylaxis.

H Darius, D J Lefer, J B Smith, A M Lefer.   

Abstract

The pathophysiology of anaphylaxis is very complex, and the sequelae of events are not fully explained in terms of the effects of histamine and peptide leukotrienes alone. Platelet-activating factor (1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine, PAF-acether) has been detected in animals undergoing anaphylaxis. Injection of synthetic PAF-acether induces similar effects, including bronchoconstriction, respiratory arrest, systemic hypotension, neutropenia, and thrombocytopenia. The results reported here demonstrate that the histamine- and leukotriene-independent component of guinea pig anaphylaxis in vivo and in isolated lung parenchymal strips in vitro is mediated by PAF-acether. However, PAF-acether is not responsible for the anaphylaxis-induced thrombocytopenia.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082008     DOI: 10.1126/science.3082008

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  17 in total

1.  The effect of WEB 2086 on PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils.

Authors:  H Miyagawa; M Nabe; R J Hopp; C Okada; A K Bewtra; G Townley
Journal:  Agents Actions       Date:  1992-09

2.  Pooling of blood in postischemic shock is modulated by platelet-activating factor (PAF).

Authors:  V F Sagach; A V Dmitrieva; P Braquet
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

3.  The role of platelet-activating factor and peptidoleukotrienes in the vascular changes of rat passive anaphylaxis.

Authors:  S Fernández-Gallardo; M A Gijón; C García; V Furio; F T Liu; M Sánchez Crespo
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

4.  Azelastine inhibits bronchial hyperreactivity to acetylcholine in guinea pigs.

Authors:  U Achterrath-Tuckermann; I Szelenyi
Journal:  Experientia       Date:  1988-12-01

5.  Suppression of PAF-induced bronchoconstriction in the guinea-pig by oxatomide: mechanism of action.

Authors:  F P Nijkamp; G Folkerts; J R Beetens; F De Clerck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

6.  The effects of PAF-acether and FMLP on eicosanoid production in guinea pig alveolar macrophages.

Authors:  F J Zijlstra; M Bachelet; M A Vermeer; J E Vincent
Journal:  Agents Actions       Date:  1989-01

7.  Pharmacological modulation of bronchial anaphylaxis induced by aerosol challenge in anaesthetized guinea-pigs.

Authors:  L Daffonchio; I W Lees; A N Payne; B J Whittle
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

Review 8.  PAF antagonists. Their potential therapeutic role in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Drugs       Date:  1988-02       Impact factor: 9.546

9.  Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin.

Authors:  H A Gelbard; H S Nottet; S Swindells; M Jett; K A Dzenko; P Genis; R White; L Wang; Y B Choi; D Zhang
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

10.  Lipoxins A4 and B4: comparison of icosanoids having bronchoconstrictor and vasodilator actions but lacking platelet aggregatory activity.

Authors:  A M Lefer; G L Stahl; D J Lefer; M E Brezinski; K C Nicolaou; C A Veale; Y Abe; J B Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.